Testosterone
Medically reviewed by Hormone Journal Editorial Team · Last reviewed 2026-05-17
Testosterone is the primary androgen (sex hormone) produced mainly in the testes and, in smaller amounts, the ovaries and adrenal glands, regulating sexual function, muscle mass, bone density, and mood.
What it is
Testosterone is the primary androgen (sex hormone) produced mainly in the testes and, in smaller amounts, the ovaries and adrenal glands, regulating sexual function, muscle mass, bone density, and mood. It belongs to a class of hormones called steroids, meaning it is built from cholesterol. Both men and women produce testosterone, though typical male levels run roughly 10–20 times higher than typical female levels. A small fraction of circulating testosterone is converted by an enzyme called aromatase into estradiol (the main form of estrogen), which means some effects once attributed solely to testosterone are partly driven by estrogen.
Causes and mechanism
The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to secrete luteinizing hormone (LH). LH then travels to the testes (or ovaries) and triggers testosterone production. This is called the hypothalamic-pituitary-gonadal (HPG) axis. Testosterone levels peak in early adulthood and decline roughly 1–2% per year after age 30–40. When the testes or ovaries cannot produce adequate testosterone — due to disease, injury, or genetic conditions — the condition is called hypogonadism. Research from Massachusetts General Hospital (Finkelstein et al., NEJM 2013) showed that some effects attributed to low testosterone, such as increased body fat, are actually driven by the accompanying drop in estradiol.
Symptoms and diagnosis
Low testosterone (hypogonadism) can cause:
- Reduced sex drive and fewer spontaneous erections
- Loss of muscle mass and strength
- Increased body fat, sometimes with breast tissue growth (gynecomastia)
- Decreased bone density, raising fracture risk
- Fatigue, low mood, and difficulty concentrating
- In women: low libido, fatigue, and reduced bone density
Diagnosis requires a morning fasting blood test measuring total testosterone, because levels fluctuate throughout the day and are highest in the morning. The Endocrine Society defines male hypogonadism as a consistently low total testosterone (generally below 300 ng/dL) combined with symptoms. A single low reading is not sufficient — at least two separate measurements are recommended before treatment is considered.
Treatment options
Treatment depends on the cause and severity:
- Testosterone replacement therapy (TRT): Available as injections, transdermal gels or patches, subcutaneous pellets, and oral or buccal formulations. Indicated for confirmed hypogonadism.
- Clomiphene citrate: An off-label oral option that stimulates the pituitary to increase LH, prompting the body's own testosterone production. Preserves fertility, unlike exogenous TRT.
- Lifestyle modification: Resistance exercise, weight loss, improved sleep, and reduced alcohol intake can raise testosterone levels modestly in men with obesity or metabolic syndrome.
Debate on "optimization" in older men: The American College of Physicians notes that TRT may modestly improve sexual function in some men, but evidence for broader benefits — energy, cognition, cardiovascular health — remains limited and mixed. The 2023 TRAVERSE trial found no significant increase in major cardiovascular events with TRT in men with hypogonadism and high cardiovascular risk, but long-term safety data beyond a few years are still limited.
When to see a clinician
See a clinician if you have persistent symptoms of low testosterone lasting more than a few weeks — especially reduced libido, unexplained fatigue, or significant muscle loss. Men under 40 with symptoms warrant evaluation for an underlying cause (e.g., pituitary tumor, genetic condition). Women experiencing unexplained low libido, fatigue, or bone loss should also ask about testosterone testing. Do not self-treat with over-the-counter supplements or unregulated products; many have not been tested for safety or efficacy.
FAQs
What is a normal testosterone level for men?
Most laboratories define the normal range for total testosterone in adult men as approximately 300–1,000 ng/dL (10.4–34.7 nmol/L), though reference ranges vary slightly by lab. The Endocrine Society recommends diagnosing hypogonadism only when levels fall below 300 ng/dL on at least 2 separate morning tests, combined with symptoms. Levels naturally decline about 1–2% per year after age 30.
What is the difference between total testosterone and free testosterone?
Total testosterone measures all testosterone in the blood, including the roughly 98% that is bound to proteins (mainly sex hormone-binding globulin, or SHBG, and albumin). Free testosterone is the unbound 1–2% that can enter cells and exert effects. Some clinicians order free testosterone when total levels are borderline, because high SHBG — common in older men and those with liver disease — can leave free testosterone low even when total levels appear normal.
Can women have low testosterone, and should they be treated?
Yes. Women produce testosterone in the ovaries and adrenal glands, and levels decline with age and after surgical menopause. The International Society for the Study of Women's Sexual Health (ISSWSH) recognizes testosterone therapy as an evidence-based option for hypoactive sexual desire disorder (HSDD) in postmenopausal women, typically at doses that restore levels to the upper end of the normal premenopausal female range (roughly 15–70 ng/dL). Long-term safety data beyond 24 months are limited, so ongoing monitoring is recommended.
Does testosterone therapy increase the risk of prostate cancer?
Current evidence does not confirm that TRT causes prostate cancer in men with no prior diagnosis. The Endocrine Society guidelines state that TRT is contraindicated in men with active or suspected prostate cancer, but the older 'testosterone fuels prostate cancer' hypothesis has been substantially revised. Men on TRT should have prostate-specific antigen (PSA) levels checked at 3–6 months after starting therapy and then annually. Any significant PSA rise warrants urological evaluation.
Is testosterone therapy covered by insurance?
In the United States, FDA-approved testosterone formulations are generally covered by insurance when hypogonadism is confirmed by lab results and documented symptoms — but coverage rules vary by plan and formulation. Gels and patches may require prior authorization, while injections (e.g., testosterone cypionate) are typically lower cost and more consistently covered. Cash prices for generic injectable testosterone can be as low as $20–$40 per month, while branded gels may exceed $300 per month without coverage.
Sources
- Benefits of Testosterone Hormone in the Human Body: A Systematic Review (PMC/Cureus, 2025)
- Impact of Testosterone on Male Health: A Systematic Review (PMC/Cureus, 2025)
- Testosterone Therapy: Potential Benefits and Risks as You Age — Mayo Clinic
- Testosterone Deficiency in Adults and Testosterone Therapy — Endocrine Society Clinical Practice Guideline
- Understanding How Testosterone Affects Men — NIH Research Matters